Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
BJU International|June 8, 2004
Identification of multidrug resistance-associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximineJ P van Brussel, M A Oomen, P J M Vossebeld, et al.European Urology|May 28, 2003
Rational selection of a control arm for randomised trials in metastatic renal cell carcinomaG H J MickischInternational Journal of Urology : Official Journal of the Japanese Urological Association|April 16, 1998
Circumvention of multidrug resistance in genitourinary tumorsJ P van Brussel, G H MickischNederlands Tijdschrift Voor Geneeskunde|June 13, 2000
[Luxatio cordis in blunt-trauma thoraco-abdominal injuries]J P van Brussel, W J Vles, L P LeenenThe Netherlands Journal of Medicine|February 10, 1998
Wilkie's syndrome, a rare cause of vomiting and weight loss: diagnosis and therapyJ P Van Brussel, W P Dijkema, S K Adhin, et al.European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Chemosensitivity of prostate cancer cell lines and expression of multidrug resistance-related proteinsJ P van Brussel, G J van Steenbrugge, J C Romijn, et al.Cancer Chemotherapy and Pharmacology|June 15, 2000
A phase II study of temozolomide in hormone-refractory prostate cancerJ P van Brussel, M B Busstra, M S Lang, et al.Cancer Chemotherapy and Pharmacology|March 27, 2002
A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapyA N Vis, A van der Gaast, B W G van Rhijn, et al.Pageof 2